✦ LIBER ✦

Results from a Single Institution Phase II Trial of Concurrent Docetaxel/Carboplatin/Radiotherapy Followed by Surgical Resection and Consolidation Docetaxel/Carboplatin in Stage III Non–Small-Cell Lung Cancer

✍ Scribed by Millie Das; Jessica S. Donington; James Murphy; Margaret Kozak; Neville Eclov; Richard I. Whyte; Chuong D. Hoang; Lisa Zhou; Quynh-Thu Le; Billy W. Loo; Heather Wakelee

Book ID: 113544769
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 326 KB
Volume: 12
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2011.06.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of carboplatin/paclitaxel/

Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer

✍ Edelman, Martin J.; Burrows, Whitney; Krasna, Mark J.; Bedor, Michelle; Smith, R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Phase II study of bi-weekly docetaxel an

Phase II study of bi-weekly docetaxel and carboplatin with concurrent thoracic radiation therapy followed by consolidation chemotherapy with docetaxel plus carboplatin for stage III unresectable non-small cell lung cancer

✍ Sakai, H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 93 KB

A California Cancer Consortium phase II

A California Cancer Consortium phase II trial of concurrent twice-weekly paclitaxel, weekly carboplatin and radiation followed by paclitaxel/carboplatin consolidation for stage III non-small-cell lung cancer

✍ Lau, D; Ryu, J; Gandara, D; Edelman, M; Israel, V; Doroshow, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Phase i/ii study of docetaxel (DOC) and

Phase i/ii study of docetaxel (DOC) and carboplatin (CBDCA) with concurrent radiotherapy in patients with stage III unresectable non-small cell lung cancer (NSCLC), preliminary results

✍ S. Kato; M. Sakura; T. Kazumoto; H. Sakai; S. Yoneda; Y. Noguchi; K. Kobayashi; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Concurrent Chemoradiotherapy Followed by

Concurrent Chemoradiotherapy Followed by Consolidation Chemotherapy With Bi-Weekly Docetaxel and Carboplatin for Stage III Unresectable, Non-Small-Cell Lung Cancer: Clinical Application of a Protocol Used in a Previous Phase II Study

✍ Jun-Ichi Saitoh; Yoshihiro Saito; Tomoko Kazumoto; Shigehiro Kudo; Daisaku Yoshi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Concurrent Chemoradiation Therapy With D

Concurrent Chemoradiation Therapy With Docetaxel/Cisplatin Followed by Docetaxel Consolidation Therapy in Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer: Results of a Phase I Study

✍ Rudolf M. Huber; Astrid Borgmeier; Michael Flentje; Jochen Willner; Michael Schm 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 379 KB